Skip to main content
. Author manuscript; available in PMC: 2023 Nov 4.
Published in final edited form as: Chembiochem. 2022 Sep 27;23(21):e202200449. doi: 10.1002/cbic.202200449

Figure 5.

Figure 5.

Competitive inhibition of the PD1/PDL1 interaction. (A) Illustration of the PDL1-competitive assay setup used to measure the hairpin 1e binding kinetics to PD1. (B) Progress curve analysis of [PD1•PDL1] formation at varying concentrations of inhibitor 1e in comparison to the full-length antibody pembrolizumab.a

a Experimental data points (mean ± s.d.) from two or four replicates (N ≥ 2) with non-linear fitted progress curves (dashed and dotted lines).